e-learning
resources
London 2016
Wednesday, 07.09.2016
Airway pharmacology: drug targets and mode of action
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Increased expression of ADRB2, CHRM3 and glucocorticoid alpha receptor genes in blood leukocytes of COPD patients
Alexey Chukhlovin (St Petersburg, Russian Federation), Alexey Chukhlovin, Olga Titova, Nikita Yolshin, Natalya Kuzubova
Source:
International Congress 2016 – Airway pharmacology: drug targets and mode of action
Session:
Airway pharmacology: drug targets and mode of action
Session type:
Poster Discussion
Number:
5059
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Alexey Chukhlovin (St Petersburg, Russian Federation), Alexey Chukhlovin, Olga Titova, Nikita Yolshin, Natalya Kuzubova. Increased expression of ADRB2, CHRM3 and glucocorticoid alpha receptor genes in blood leukocytes of COPD patients. Eur Respir J 2016; 48: Suppl. 60, 5059
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Expression of estrogen receptors and estrogen metabolism genes in lungs of COPD patients
Source: International Congress 2015 – Inflammation and remodelling in lung disease
Year: 2015
Changes in the populations of blood T-lymphocytes containing chemokine receptors in non-smoking patients with COPD
Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung
Year: 2013
The role of glucocorticoid receptor a and ß isoforms in exacerbations of asthma, COPD, and ACOS
Source: International Congress 2017 – Gene signatures in bronchial diseases
Year: 2017
Polymorphic variants of genes ADRB2, NR3C1, MDR1 in patients with chronic obstructive pulmonary disease and obesity
Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD
Year: 2015
Neutrophils and neutrophil chemokine receptor (CXCR1 and 2) gene expression in severe exacerbations of COPD and asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 501s
Year: 2001
Platelet activating factor receptor (PAFr) expression is increased in airways of COPD patients but is not attenuated by inhaled corticosteroid (ICS)
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Association of polymorphisms in interleukin-13 receptor pathway genes with atopy and lung function in asthmatics
Source: Annual Congress 2008 - Understanding airway inflammation
Year: 2008
Leptin receptor polymorphisms and lung function decline in COPD
Source: Eur Respir J 2009; 34: 103-110
Year: 2009
Sputum cell mRNA transcripts demonstrate alteration of endothelin metabolism in severe asthma and COPD
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013
Glucocorticosteroid receptor (GCR) gene isoforms expression in bronchial asthma (BA) patients
Source: Annual Congress 2011 - Asthma: a heterogeneous disease
Year: 2011
ADRB2 Gly16Arg polymorphism, asthma control and lung function decline
Source: Eur Respir J 2011; 38: 1029-1035
Year: 2011
-82 A>G promoter polymorphism in the gene of human macrophage elastase (MMP-12) as a risk factor for COPD and bronchial asthma
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014
The median number of COPD exacerbations per year in patients with different polymorphisms of the gene ADRB2
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
?2-adrenergic receptor polymorphisms, asthma and COPD: two large population-based studies
Source: Eur Respir J 2012; 39: 558-566
Year: 2012
Expression of vascular remodeling markers in relation to bradykinin receptors in asthma and COPD
Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases
Year: 2013
Increased interferon and decreased NRF2-PPARG signaling is associated with frequent exacerbations in COPD
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015
Genetic association studies of interleukin-13 receptor α1 subunit gene polymorphisms in asthma and atopy
Source: Eur Respir J 2007; 30: 40-47
Year: 2007
Decreased toll-like receptor 4 expression in induced sputum associated with increased frequency of acute exacerbation in COPD patients
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009
Expression of adenosine receptors in the peripheral lung from COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 13s
Year: 2005
Altered P2 receptor expression profile in sputum cells of patients with COPD
Source: International Congress 2014 – Monitoring COPD with different biomarkers
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept